E-LIB Suche - Ergebnisse für: Nakata, Masao

1

Ion-core switching in Rydberg series of XeKr:

Fukuda, Yuji ; Szidarovszky, Tamás ; Nakata, Masao..
Molecular Physics. , 2024

2

Automated immunoassay of serum NY-ESO-1 and XAGE1 antibodie..:

Sakaeda, Kanako ; Kurose, Koji ; Matsumura, Yuki...
Cancer Treatment and Research Communications. 40 (2024) - p. 100830 , 2024

Link: https://doi.org/10.1016/..

3

Randomized phase II study of daily versus alternate-day adm..:

Yamamoto, Hiromasa ; Soh, Junichi ; Okumura, Norihito...
PLOS ONE. 18 (2023) 5 - p. e0285273 , 2023

Link: https://doi.org/10.1371/..

4

A case of pleuroperitoneal communication during long-term s..:

Takasu, Masanobu ; Kadoya, Hiroyuki ; Yamanouchi, Yu...
Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 42 (2022) 4 - p. 434-436 , 2022

Link: https://doi.org/10.1177/..

5

Effects of tumor-infiltrating CD8+ T cells, PD1/PD-L1 axis,..:

Okita, Riki ; Mimura-Kimura, Yuka ; Kawamoto, Nobutaka...
Cancer Immunology, Immunotherapy. 72 (2022) 4 - p. 865-879 , 2022

Link: https://doi.org/10.1007/..

6

Tofacitinib overcomes an IFNγ‐induced decrease in NK cell‐m..:

Okita, Riki ; Shimizu, Katsuhiko ; Nojima, Yuji..
Thoracic Cancer. 12 (2021) 6 - p. 775-782 , 2021

Link: https://doi.org/10.1111/..

7

Randomized phase II study of daily and alternate-day admini..:

Okumura, Norihito ; Soh, Junichi ; Suzuki, Hiroyuki...
BMC Cancer. 21 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

8

Serum Antibody Against NY-ESO-1 and XAGE1 Antigens Potentia..:

Ohue, Yoshihiro ; Kurose, Koji ; Karasaki, Takahiro...
Journal of Thoracic Oncology. 14 (2019) 12 - p. 2071-2083 , 2019

Link: https://doi.org/10.1016/..

9

Comparative study of the PD-L1 expression and CD8+ tumor-in..:

Shimizu, Katsuhiko ; Okita, Riki ; Saisho, Shinsuke...
Therapeutics and Clinical Risk Management. 15 (2019) - p. 605-612 , 2019

Link: https://doi.org/10.2147/..

10

Impact of pathological stage and histological subtype on cl..:

Soh, Junichi ; Toyooka, Shinichi ; Okumura, Norihito...
International Journal of Clinical Oncology. 24 (2019) 11 - p. 1367-1376 , 2019

Link: https://doi.org/10.1007/..

11

Clinicopathological relevance of tumor expression of NK gro..:

Okita, Riki ; Maeda, Ai ; Shimizu, Katsuhiko...
Oncotarget. 10 (2019) 63 - p. 6805-6815 , 2019

Link: https://doi.org/10.18632..

12

P3.01-008 Clinicopathological and Immunohistochemical Featu..:

Nojima, Yuji ; Shimizu, Katsuhiko ; Maeda, Ai...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S1123 , 2017

Link: https://doi.org/10.1016/..

13

Prognostic value of Cox-2 and PD-L1 expression and its rela..:

Shimizu, Katsuhiko ; Okita, Riki ; Saisho, Shinsuke...
Cancer Management and Research. 9 (2017) - p. 741-750 , 2017

Link: https://doi.org/10.2147/..

14

PD-L1 overexpression is partially regulated by EGFR/HER2 si..:

Okita, Riki ; Maeda, Ai ; Shimizu, Katsuhiko...
Cancer Immunology, Immunotherapy. 66 (2017) 7 - p. 865-876 , 2017

Link: https://doi.org/10.1007/..

15

Randomized feasibility study of S-1 for adjuvant chemothera..:

Soh, Junichi ; Okumura, Norihito ; Nakata, Masao...
Japanese Journal of Clinical Oncology. 46 (2016) 8 - p. 741-747 , 2016

Link: https://doi.org/10.1093/..